The impact of managed entry agreements on pharmaceutical prices

6 July 2020 - Managed entry agreements have been used for several years, with the aim of curbing the growth of ...

Read more →

Astex Pharmaceuticals, Taiho Oncology and Otsuka Pharmaceutical announce Health Canada approval of Inqovi (decitabine and cedazuridine) tablets, oral hypomethylating agent therapy for intermediate and high-risk MDS and C

7 July 2020 - Inqovi is the first orally administered hypomethylating agent approved by the FDA and Health Canada. ...

Read more →

CorMedix reports submission of Defencath new drug application

8 July 2020 - CorMedix today announced that all of the modules for the Defencath new drug application have been submitted ...

Read more →

PHARMAC to remove medicine dispensing restrictions

9 July 2020 - Most funded medicines will return to all at once dispensing because PHARMAC is removing most of ...

Read more →

So just who do we think qualifies for any COVID-19 vaccine?

 9 July 2020 - How should we allocate scarce medical resources? ...

Read more →

House proposes $3.2 billion for FDA in FY 2021

7 July 2020 - On Monday, the US House Committee on Appropriations’ Subcommittee on Agriculture, Rural Development, Food and Drug ...

Read more →

Drug prices steadily rise amid pandemic, data shows

7 July 2020 - Some drugmakers have delayed or staggered increases amid increased scrutiny and the fear of catching President Donald ...

Read more →

A flawed COVID-19 study gets the White House’s attention — and the FDA may pay the price

8 July 2020 - Studies in thousands of people on multiple continents now show the malaria drug hydroxychloroquine does not ...

Read more →

TLV is reviewing the subsidy of SGLT-2 inhibitors

8 July 2020 - TLV has started a review of subsidy restrictions for the SGLT-2 inhibitors. ...

Read more →

Concert Pharmaceuticals receives FDA breakthrough therapy designation for CTP-543 for the treatment of alopecia areata

8 July 2020 - Designation based on Phase 2 data demonstrating significant hair regrowth in patients with alopecia areata. ...

Read more →

ICER reschedules cystic fibrosis public meeting for 27 August 2020

8 July 2020 - Registration is now open. ...

Read more →

Biogen completes submission of biologics license application to FDA for aducanumab as a treatment for Alzheimer’s disease

8 July 2020 - If approved, aducanumab would be the first treatment with the potential to meaningfully change the course of ...

Read more →

Merck and Eisai receive complete response letter for Keytruda (pembrolizumab) plus Lenvima (lenvatinib) combination as first-line treatment for unresectable hepatocellular carcinoma

8 July 2020 - Merck and Eisai today announced that the U.S. FDA has issued a complete response letter regarding Merck’s ...

Read more →

Lynparza approved in the EU for BRCA mutated metastatic pancreatic cancer

8 July 2020 - Only PARP inhibitor approved in this disease. ...

Read more →

ISPOR Working Group provides a first-ever cross-stakeholder consensus definition of “Patient Engagement in Research”

 7 July 2020 - Value in Health announced today the publication of results of an ISPOR systematic review and analysis ...

Read more →

Remove the disincentives and biosimilars will flourish, policy expert says

7 July 2020 - Patients could save as much as 17% on out-of-pocket costs if they used biosimilars, but many ...

Read more →